Aditxt, Inc. (ADTX): Total Assets
$16.52M
As of 2025-12-31
$13.91M
As of 2026-03-31
+15.4%
3-year compound annual growth
+4.7%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.52M | -48.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $32.14M | -27.9% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $44.58M | +315.3% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $10.74M | -35.6% | 2024-04-16, Balance as of period end |
| 2021-12-31 | $16.66M | +27.2% | 2023-04-17, Balance as of period end |
| 2020-12-31 | $13.10M | n/m | 2022-03-31, Balance as of period end |
| 2019-12-31 | $123.5K | n/a | 2021-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | 2025-12-31 | $16.52M | -48.6% |
| One World Products, Inc. (OWPC) | 2024-12-31 | $68.3K | -30.9% |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | $2.97M | +7.7% |
| Aspire Biopharma Holdings, Inc. (ASBP) | 2025-12-31 | $1.31M | +786.7% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.03M | -45.2% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $225.9K | -13.7% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $127.6K | -19.4% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $5.56M | -10.3% |
Compare ADTX, OWPC, TCRT, ASBP side by side · Screen every company in Pharmaceutical Preparations ↗